C12 Dihydroceramide (d18:0/12:0)
| Catalog Number | BL-M001041 |
| CAS Number | 197302-96-8 |
| Description | Dihydroceramide (d18:0/12:0), also known as C12, is a lipid compound extensively studied for its implications in cancer treatment, particularly in modulating cancer cell metabolic functions and cellular survival mechanisms. Research suggests a potential association with neurodegenerative conditions through intricate involvement in cellular signaling cascades. |
 | |
| IUPAC Name | N-[(2S,3R)-1,3-dihydroxyoctadecan-2-yl]dodecanamide |
| Synonyms | N-lauroyl-D-erythro-sphinganine; N-dodecanoylsphinganine; Cer(d18:0/12:0); N-12:0 Sphinganine; C12 Sphinganine; C12 dihydrosphingosine; N-(dodecanoyl)-sphinganine; N-lauroylsphinganine; N-lauroyldihydrosphingosine; N-dodecanoyldihydrosphingosine; Dodecanamide, N-[(1S,2R)-2-hydroxy-1-(hydroxymethyl)heptadecyl]-; C12:0 DHCer |
| Molecular Weight | 483.81 |
| Molecular Formula | C30H61NO3 |
| Boiling Point | 636.3±45.0°C at 760 mmHg |
| Purity | >99% |
| Density | 0.9±0.1 g/cm3 |
| Appearance | White Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 74.48%, H 12.71%, N 2.90%, O 9.92% |
| Canonical SMILES | CCCCCCCCCCCCCCCC(C(CO)NC(=O)CCCCCCCCCCC)O |
| InChI | InChI=1S/C30H61NO3/c1-3-5-7-9-11-13-14-15-16-18-19-21-23-25-29(33)28(27-32)31-30(34)26-24-22-20-17-12-10-8-6-4-2/h28-29,32-33H,3-27H2,1-2H3,(H,31,34)/t28-,29+/m0/s1 |
| InChI Key | UHWYQXNZIBLESO-URLMMPGGSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
